Ionis Pharmaceuticals Inc
IONSHealthcare|Biotechnology|USA
$58.25
-6.02 (-9.37%)
Tangible Book
$2.96
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (411)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Diaz Allene M. | Director | 2026-07-07 | SELL | 10,111 | $85.42 | $863.7K |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | 2026-07-07 | SELL | 362 | $84.3 | $30.5K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026-07-07 | SELL | 20,536 | $84.95 | $1744.5K |
| KLEIN JOSEPH III | Director | 2026-07-01 | SELL | 11,518 | $79.04 | $910.4K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-06-26 | SELL | 5,635 | $80.16 | $451.7K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2026-06-26 | SELL | 3,069 | $80 | $245.5K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2026-06-26 | SELL | 26,000 | $81.05 | $2107.3K |
| Monia Brett P | CEO | 2026-06-26 | SELL | 85,637 | $79.7 | $6825.3K |
| Swayze Eric | EVP Research | 2026-06-25 | SELL | 10,602 | $79.18 | $839.5K |
| BERTHELSEN SPENCER R | Director | 2026-06-15 | SELL | 8,000 | $73.49 | $587.9K |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | 2026-06-12 | SELL | 60,846 | $73.41 | $4466.7K |
| BERTHELSEN SPENCER R | Director | 2026-06-01 | SELL | 8,000 | $75.67 | $605.4K |
| Monia Brett P | CEO | 2026-05-14 | SELL | 4,536 | $78.49 | $356K |
| LOSCALZO JOSEPH | Director | 2026-05-04 | SELL | 77,289 | $75.06 | $5801.3K |
| KLEIN JOSEPH III | Director | 2026-05-01 | SELL | 10,111 | $73.51 | $743.3K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-04-28 | SELL | 1,626 | $71.79 | $116.7K |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | 2026-04-16 | SELL | 4,902 | $75.17 | $368.5K |
| Birchler Brian | EVP, Corp and Development Ops | 2026-04-16 | SELL | 973 | $75.04 | $73K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-04-16 | SELL | 5,619 | $74.56 | $419K |
| PARSHALL B LYNNE | Director | 2026-04-15 | SELL | 5,000 | $76.27 | $381.4K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2026-04-02 | SELL | 6,193 | $74.05 | $458.6K |
| KLEIN JOSEPH III | Director | 2026-04-01 | SELL | 22,321 | $75.55 | $1686.4K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2026-03-19 | SELL | 5,812 | $70.97 | $412.5K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2026-03-17 | SELL | 225,220 | $72.43 | $16312.7K |
| Monia Brett P | CEO | 2026-03-10 | SELL | 160,773 | $75.35 | $12114.2K |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | 2026-03-10 | SELL | 37,277 | $75.85 | $2827.5K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2026-03-09 | SELL | 10,148 | $75.25 | $763.6K |
| LOSCALZO JOSEPH | Director | 2026-03-04 | SELL | 1,032 | $80.26 | $82.8K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-03-04 | SELL | 6,659 | $79.74 | $531K |
| KLEIN JOSEPH III | Director | 2026-03-03 | SELL | 21,332 | $79.51 | $1696.1K |
| Diaz Allene M. | Director | 2026-03-03 | SELL | 54,878 | $79.35 | $4354.6K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2026-03-03 | SELL | 20,106 | $79.4 | $1596.4K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026-03-03 | SELL | 85,089 | $79.23 | $6741.6K |
| Swayze Eric | EVP Research | 2026-02-13 | SELL | 15,642 | $81.76 | $1278.9K |
| PARSHALL B LYNNE | Director | 2026-02-11 | SELL | 5,000 | $82.72 | $413.6K |
| Monia Brett P | CEO | 2026-02-06 | SELL | 29,430 | $85.79 | $2524.8K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026-02-02 | SELL | 85,089 | $82.93 | $7056.4K |
| Swayze Eric | EVP Research | 2026-01-30 | SELL | 6,179 | $82.93 | $512.4K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2026-01-30 | SELL | 6,179 | $83.45 | $515.6K |
| Monia Brett P | CEO | 2026-01-30 | SELL | 62,970 | $82.72 | $5208.9K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2026-01-30 | SELL | 6,988 | $83.24 | $581.7K |
| Birchler Brian | EVP, Corp and Development Ops | 2026-01-30 | SELL | 6,179 | $83.03 | $513K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026-01-30 | SELL | 5,885 | $82.95 | $488.2K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-01-30 | SELL | 5,296 | $82.96 | $439.4K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2026-01-22 | SELL | 3,977 | $81.34 | $323.5K |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | 2026-01-16 | SELL | 1,823 | $75.96 | $138.5K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2026-01-16 | SELL | 12,922 | $75.22 | $972K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2026-01-16 | SELL | 8,353 | $75.95 | $634.4K |
| Birchler Brian | EVP, Corp and Development Ops | 2026-01-16 | SELL | 8,480 | $75.11 | $636.9K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2026-01-16 | SELL | 8,977 | $75.15 | $674.6K |
| Baroldi Joseph | EVP, Chief Business Officer | 2026-01-16 | SELL | 8,056 | $75.75 | $610.2K |
| Swayze Eric | EVP Research | 2026-01-16 | SELL | 9,933 | $75.34 | $748.4K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2026-01-16 | SELL | 9,302 | $75.59 | $703.1K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2026-01-16 | SELL | 9,191 | $75.84 | $697K |
| Monia Brett P | CEO | 2026-01-16 | SELL | 44,034 | $74.82 | $3294.6K |
| Kordasiewicz Holly B. | EVP, Chief Development Officer | 2026-01-16 | SELL | 4,141 | $75.66 | $313.3K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2026-01-07 | SELL | 44,199 | $85.08 | $3760.5K |
| Swayze Eric | EVP Research | 2026-01-02 | SELL | 23,463 | $79.12 | $1856.4K |
| WENDER JOSEPH H | Director | 2025-12-01 | SELL | 28,000 | $80.82 | $2263K |
| KLEIN JOSEPH III | Director | 2025-11-25 | SELL | 12,000 | $80 | $960K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2025-11-25 | SELL | 16,777 | $80.91 | $1357.4K |
| HERMAN JOAN E | Director | 2025-11-19 | SELL | 44,000 | $72.13 | $3173.7K |
| Birchler Brian | EVP, Corp and Development Ops | 2025-11-06 | SELL | 8,000 | $76.17 | $609.4K |
| Geary Richard S | EVP, Chief Development Officer | 2025-11-03 | SELL | 1,680 | $75.05 | $126.1K |
| Geary Richard S | EVP, Chief Development Officer | 2025-11-03 | SELL | 90,929 | $75.11 | $6829.7K |
| WENDER JOSEPH H | Director | 2025-10-31 | SELL | 28,000 | $74.02 | $2072.6K |
| LOSCALZO JOSEPH | Director | 2025-10-31 | SELL | 16,000 | $75.1 | $1201.6K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2025-10-16 | SELL | 7,263 | $73.06 | $530.6K |
| PARSHALL B LYNNE | Director | 2025-10-15 | SELL | 5,000 | $71.74 | $358.7K |
| Birchler Brian | EVP, Corp and Development Ops | 2025-10-15 | SELL | 23,900 | $72.13 | $1723.9K |
| Swayze Eric | EVP Research | 2025-10-06 | SELL | 6,849 | $69.02 | $472.7K |
| Monia Brett P | CEO | 2025-10-06 | SELL | 437 | $69.26 | $30.3K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-10-06 | SELL | 13,441 | $69.74 | $937.4K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-10-06 | SELL | 1,625 | $69.37 | $112.7K |
| Swayze Eric | EVP Research | 2025-10-02 | SELL | 27,114 | $66.16 | $1793.9K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-10-02 | SELL | 64,664 | $67.69 | $4377.1K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-10-02 | SELL | 15,000 | $68.01 | $1020.2K |
| WENDER JOSEPH H | Director | 2025-10-01 | SELL | 16,800 | $65.5 | $1100.4K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-09-30 | SELL | 25,300 | $64.62 | $1634.9K |
| Geary Richard S | EVP, Chief Development Officer | 2025-09-30 | SELL | 57,900 | $65.24 | $3777.4K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2025-09-30 | SELL | 49,800 | $65.26 | $3249.9K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-09-12 | SELL | 1,700 | $64.58 | $109.8K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-09-09 | SELL | 11,950 | $62.16 | $742.8K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-09-09 | SELL | 21,000 | $64.56 | $1355.8K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-09-05 | SELL | 250 | $62 | $15.5K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2025-09-05 | SELL | 6,000 | $59.6 | $357.6K |
| WENDER JOSEPH H | Director | 2025-09-03 | SELL | 28,000 | $57.58 | $1612.2K |
| Monia Brett P | CEO | 2025-09-03 | SELL | 203,814 | $60.32 | $12294.1K |
| KLEIN JOSEPH III | Director | 2025-09-03 | SELL | 28,000 | $60 | $1680K |
| KLEIN JOSEPH III | Director | 2025-09-03 | SELL | 28,000 | $60 | $1680K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2025-09-03 | SELL | 3,162 | $61.02 | $192.9K |
| WENDER JOSEPH H | Director | 2025-09-03 | SELL | 28,000 | $57.58 | $1612.2K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-09-03 | SELL | 32,800 | $59.34 | $1946.4K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-09-03 | SELL | 89,900 | $60.03 | $5396.7K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2025-09-03 | SELL | 38,909 | $59.14 | $2301.1K |
| LOSCALZO JOSEPH | Director | 2025-09-03 | SELL | 16,000 | $60.15 | $962.4K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2025-09-03 | SELL | 19,658 | $60.81 | $1195.4K |
| Swayze Eric | EVP Research | 2025-09-02 | SELL | 11,130 | $49.67 | $552.8K |
| PARSHALL B LYNNE | Director | 2025-09-02 | SELL | 20,000 | $50.91 | $1018.2K |
| Geary Richard S | EVP, Chief Development Officer | 2025-09-02 | SELL | 10,000 | $50.37 | $503.7K |
| Diaz Allene M. | Director | 2025-08-22 | SELL | 1,427 | $42.53 | $60.7K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2025-08-18 | SELL | 10,000 | $43.98 | $439.8K |
| PARSHALL B LYNNE | Director | 2025-08-06 | SELL | 5,000 | $41.93 | $209.7K |
| Geary Richard S | EVP, Chief Development Officer | 2025-08-05 | SELL | 10,000 | $42.86 | $428.6K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2025-08-04 | SELL | 9,549 | $42.8 | $408.7K |
| Monia Brett P | CEO | 2025-07-30 | SELL | 2,432 | $45 | $109.4K |
| Monia Brett P | CEO | 2025-07-11 | SELL | 1,160 | $41.74 | $48.4K |
| Hayden Michael R | Director | 2025-05-01 | BUY | 15,000 | $31.86 | $477.9K |
| Birchler Brian | EVP, Corp and Development Ops | 2025-04-16 | SELL | 680 | $28.37 | $19.3K |
| Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | 2025-04-16 | SELL | 3,016 | $28.36 | $85.5K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-04-16 | SELL | 3,928 | $28.4 | $111.6K |
| Monia Brett P | CEO | 2025-03-11 | SELL | 140 | $32.32 | $4.5K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-02-20 | SELL | 1,207 | $32.35 | $39K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-02-04 | SELL | 6,165 | $31.62 | $194.9K |
| Monia Brett P | CEO | 2025-02-04 | SELL | 38,843 | $31.65 | $1229.4K |
| Swayze Eric | EVP Research | 2025-01-31 | SELL | 1,367 | $32.31 | $44.2K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2025-01-31 | SELL | 1,484 | $32.2 | $47.8K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-01-31 | SELL | 1,406 | $32.49 | $45.7K |
| Monia Brett P | CEO | 2025-01-31 | SELL | 13,242 | $32.45 | $429.7K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2025-01-31 | SELL | 1,523 | $32.44 | $49.4K |
| Geary Richard S | EVP, Chief Development Officer | 2025-01-31 | SELL | 1,406 | $32.4 | $45.6K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2025-01-31 | SELL | 1,327 | $32.46 | $43.1K |
| Swayze Eric | EVP Research | 2025-01-16 | SELL | 7,176 | $32.84 | $235.7K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2025-01-16 | SELL | 6,523 | $32.79 | $213.9K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2025-01-16 | SELL | 7,360 | $32.83 | $241.6K |
| Monia Brett P | CEO | 2025-01-16 | SELL | 33,445 | $32.63 | $1091.3K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2025-01-16 | SELL | 8,870 | $32.81 | $291K |
| Geary Richard S | EVP, Chief Development Officer | 2025-01-16 | SELL | 7,072 | $32.86 | $232.4K |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | 2025-01-16 | SELL | 4,267 | $32.78 | $139.9K |
| Birchler Brian | EVP, Corp and Development Ops | 2025-01-16 | SELL | 5,400 | $32.7 | $176.6K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2025-01-16 | SELL | 6,752 | $32.9 | $222.1K |
| Baroldi Joseph | EVP, Chief Business Officer | 2025-01-16 | SELL | 4,430 | $32.7 | $144.9K |
| Hayden Michael R | Director | 2024-12-23 | BUY | 5,000 | $36.22 | $181.1K |
| Swayze Eric | EVP Research | 2024-11-12 | SELL | 1,194 | $37.92 | $45.3K |
| Monia Brett P | CEO | 2024-11-12 | SELL | 6,630 | $38.05 | $252.3K |
| LOSCALZO JOSEPH | Director | 2024-11-12 | SELL | 13,508 | $37.86 | $511.4K |
| Swayze Eric | EVP Research | 2024-10-16 | SELL | 53 | $38.31 | $2K |
| Geary Richard S | EVP, Chief Development Officer | 2024-08-29 | SELL | 651 | $49.4 | $32.2K |
| Geary Richard S | EVP, Chief Development Officer | 2024-08-05 | SELL | 2,430 | $48 | $116.6K |
| KLEIN JOSEPH III | Director | 2024-07-16 | SELL | 12,000 | $50 | $600K |
| Diaz Allene M. | Director | 2024-07-16 | SELL | 1,637 | $49.49 | $81K |
| BERTHELSEN SPENCER R | Director | 2024-06-17 | SELL | 16,000 | $40.29 | $644.6K |
| KLEIN JOSEPH III | Director | 2024-05-03 | SELL | 6,000 | $42.71 | $256.3K |
| Baroldi Joseph | EVP, Chief Business Officer | 2024-04-16 | SELL | 4,006 | $41.6 | $166.6K |
| Birchler Brian | EVP, Corp and Development Ops | 2024-04-16 | SELL | 905 | $41.66 | $37.7K |
| Monia Brett P | CEO | 2024-02-16 | SELL | 387 | $44.49 | $17.2K |
| Swayze Eric | EVP Research | 2024-02-02 | SELL | 1,940 | $49.56 | $96.1K |
| Monia Brett P | CEO | 2024-02-02 | SELL | 23,907 | $49.37 | $1180.3K |
| Monia Brett P | CEO | 2024-02-02 | SELL | 23,907 | $49.37 | $1180.3K |
| Geary Richard S | EVP, Chief Development Officer | 2024-02-02 | SELL | 1,995 | $50.04 | $99.8K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2024-02-02 | SELL | 2,162 | $49.54 | $107.1K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2024-02-02 | SELL | 1,995 | $49.67 | $99.1K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2024-02-02 | SELL | 2,106 | $49.59 | $104.4K |
| Cadoret-Manier Onaiza | EVP,Chf GL Pdt Str & Oper Ofc | 2024-02-02 | SELL | 2,162 | $49.6 | $107.2K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2024-02-02 | SELL | 1,885 | $49.52 | $93.3K |
| Swayze Eric | EVP Research | 2024-02-02 | SELL | 12,680 | $51.63 | $654.7K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2024-02-02 | SELL | 2,071 | $49.59 | $102.7K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2024-02-02 | SELL | 1,961 | $49.67 | $97.4K |
| Monia Brett P | CEO | 2024-02-02 | SELL | 23,501 | $49.37 | $1160.2K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2024-02-02 | SELL | 2,125 | $49.54 | $105.3K |
| Geary Richard S | EVP, Chief Development Officer | 2024-02-02 | SELL | 1,961 | $50.04 | $98.1K |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 2024-02-02 | SELL | 2,125 | $49.6 | $105.4K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2024-02-02 | SELL | 1,853 | $49.52 | $91.8K |
| Monia Brett P | CEO | 2024-01-25 | SELL | 2,285 | $51.75 | $118.2K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2024-01-25 | SELL | 6,450 | $51.75 | $333.8K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2024-01-17 | SELL | 7,744 | $50.42 | $390.5K |
| Birchler Brian | EVP, Corp and Development Ops | 2024-01-17 | SELL | 4,497 | $50.42 | $226.7K |
| Swayze Eric | EVP Research | 2024-01-17 | SELL | 6,305 | $50.42 | $317.9K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2024-01-17 | SELL | 5,482 | $50.42 | $276.4K |
| Monia Brett P | CEO | 2024-01-17 | SELL | 32,059 | $50.42 | $1616.4K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2024-01-17 | SELL | 8,683 | $50.42 | $437.8K |
| Geary Richard S | EVP, Chief Development Officer | 2024-01-17 | SELL | 7,338 | $50.42 | $370K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2024-01-17 | SELL | 6,745 | $50.42 | $340.1K |
| Baroldi Joseph | EVP, Chief Business Officer | 2024-01-17 | SELL | 2,024 | $50.42 | $102.1K |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 2024-01-17 | SELL | 5,564 | $50.42 | $280.5K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2024-01-12 | SELL | 8,000 | $53.5 | $428K |
| PARSHALL B LYNNE | Director | 2023-12-28 | SELL | 117,638 | $50.48 | $5938.4K |
| Swayze Eric | EVP Research | 2023-12-28 | SELL | 27,100 | $50.19 | $1360.1K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2023-12-26 | SELL | 20,825 | $51.46 | $1071.7K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2023-12-26 | SELL | 25,000 | $51.46 | $1286.5K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2023-12-21 | SELL | 22,613 | $49.39 | $1116.9K |
| Geary Richard S | EVP, Chief Development Officer | 2023-12-21 | SELL | 10,612 | $49.5 | $525.3K |
| Monia Brett P | CEO | 2023-12-21 | SELL | 24,000 | $49.38 | $1185.1K |
| Geary Richard S | EVP, Chief Development Officer | 2023-12-14 | SELL | 10,613 | $49.58 | $526.2K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2023-12-14 | SELL | 22,612 | $49.58 | $1121.1K |
| Monia Brett P | CEO | 2023-12-14 | SELL | 24,000 | $49.58 | $1189.9K |
| KLEIN JOSEPH III | Director | 2023-11-15 | SELL | 2,000 | $50 | $100K |
| Swayze Eric | EVP Research | 2023-10-17 | SELL | 52 | $47.95 | $2.5K |
| Monia Brett P | CEO | 2023-10-12 | SELL | 3,770 | $46 | $173.4K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2023-09-28 | SELL | 4,460 | $46.5 | $207.4K |
| PARSHALL B LYNNE | Director | 2023-09-26 | SELL | 10,000 | $45.13 | $451.3K |
| KLEIN JOSEPH III | Director | 2023-09-26 | SELL | 2,000 | $45.13 | $90.3K |
| Diaz Allene M. | Director | 2023-08-01 | SELL | 657 | $41.05 | $27K |
| KLEIN JOSEPH III | Director | 2023-07-18 | SELL | 3,555 | $42 | $149.3K |
| Monia Brett P | CEO | 2023-07-07 | SELL | 18,650 | $42.25 | $788K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2023-05-24 | SELL | 1,527 | $41.7 | $63.7K |
| Monia Brett P | CEO | 2023-05-22 | SELL | 4,931 | $40.14 | $197.9K |
| Birchler Brian | EVP, Corp and Development Ops | 2023-04-18 | SELL | 672 | $36.5 | $24.5K |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 2023-04-18 | SELL | 2,582 | $36.5 | $94.2K |
| Baroldi Joseph | EVP, Chief Business Officer | 2023-04-18 | SELL | 3,880 | $36.5 | $141.6K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2023-02-06 | SELL | 1,413 | $40.67 | $57.5K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2023-02-06 | SELL | 1,920 | $40.86 | $78.5K |
| Monia Brett P | CEO | 2023-02-06 | SELL | 24,651 | $40.69 | $1003K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2023-02-06 | SELL | 2,079 | $40.59 | $84.4K |
| Geary Richard S | EVP, Chief Development Officer | 2023-02-06 | SELL | 1,920 | $40.66 | $78.1K |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 2023-02-06 | SELL | 1,451 | $40.66 | $59K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2023-02-06 | SELL | 1,813 | $40.57 | $73.6K |
| Swayze Eric | EVP Research | 2023-02-06 | SELL | 1,815 | $40.79 | $74K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2023-01-31 | SELL | 9,000 | $39.56 | $356K |
| Swayze Eric | EVP Research | 2023-01-18 | SELL | 5,631 | $39.74 | $223.8K |
| Schneider Eugene | EVP, Chf Clinical Develop Ofcr | 2023-01-18 | SELL | 4,752 | $39.57 | $188K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2023-01-18 | SELL | 7,836 | $39.49 | $309.4K |
| Monia Brett P | CEO | 2023-01-18 | SELL | 25,066 | $39.49 | $989.9K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2023-01-18 | SELL | 8,280 | $39.7 | $328.7K |
| Geary Richard S | EVP, Chief Development Officer | 2023-01-18 | SELL | 7,873 | $39.57 | $311.5K |
| Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str & Oper Ofc | 2023-01-18 | SELL | 3,748 | $39.55 | $148.2K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2023-01-18 | SELL | 6,978 | $38.89 | $271.4K |
| Baroldi Joseph | EVP, Chief Business Officer | 2023-01-18 | SELL | 375 | $39.79 | $14.9K |
| KLEIN JOSEPH III | Director | 2023-01-17 | SELL | 2,000 | $40 | $80K |
| Swayze Eric | EVP Research | 2022-09-08 | SELL | 460 | $44.55 | $20.5K |
| Swayze Eric | EVP Research | 2022-08-05 | SELL | 1 | $45.2 | $0K |
| KLEIN JOSEPH III | Director | 2022-07-15 | SELL | 1,333 | $38.24 | $51K |
| Swayze Eric | EVP Research | 2022-04-21 | SELL | 378 | $44.15 | $16.7K |
| O'NEIL PATRICK R. | EVP CLO & General Counsel | 2022-04-12 | SELL | 6,792 | $40.06 | $272.1K |
| Monia Brett P | CEO | 2022-04-01 | SELL | 355 | $37.49 | $13.3K |
| KLEIN JOSEPH III | Director | 2021-07-15 | SELL | 4,334 | $35.3 | $153K |
| BERTHELSEN SPENCER R | Director | 2021-06-23 | SELL | 15,000 | $37.74 | $566.1K |
| MUTO FREDERICK T | Director | 2021-06-15 | SELL | 15,000 | $36.63 | $549.5K |
| Monia Brett P | CEO | 2021-03-01 | SELL | 236 | $54.28 | $12.8K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2021-01-26 | SELL | 28,333 | $63.74 | $1805.9K |
| O'NEIL PATRICK R. | EVP & General Counsel | 2021-01-25 | SELL | 5,324 | $63.5 | $338.1K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2021-01-22 | SELL | 75,000 | $61.45 | $4608.8K |
| Geary Richard S | EVP, Chief Development Offc | 2021-01-13 | SELL | 141 | $59.5 | $8.4K |
| Swayze Eric | EVP, Research | 2021-01-05 | SELL | 195 | $55.99 | $10.9K |
| PARSHALL B LYNNE | Director | 2020-12-23 | SELL | 10,000 | $60 | $600K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-12-17 | SELL | 40,407 | $49.8 | $2012.3K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-12-07 | SELL | 11,000 | $51.67 | $568.4K |
| Monia Brett P | CEO | 2020-12-04 | SELL | 23,840 | $51.04 | $1216.8K |
| BENNETT C FRANK | Chief Scientific Officer | 2020-12-04 | SELL | 7,947 | $51.04 | $405.6K |
| BENNETT C FRANK | Chief Scientific Officer | 2020-12-02 | SELL | 7,053 | $51.32 | $362K |
| Monia Brett P | CEO | 2020-12-02 | SELL | 21,160 | $51.32 | $1085.9K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2020-11-25 | SELL | 21,680 | $50.05 | $1085.1K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-11-25 | SELL | 12,990 | $50.05 | $650.1K |
| Geary Richard S | EVP, Development | 2020-11-25 | SELL | 11,920 | $50.05 | $596.6K |
| PARSHALL B LYNNE | Director | 2020-11-25 | SELL | 3,590 | $50.05 | $179.7K |
| HOUGEN ELIZABETH L | EVP, Finance & CFO | 2020-11-24 | SELL | 23,320 | $50.24 | $1171.6K |
| Geary Richard S | EVP, Development | 2020-11-24 | SELL | 13,080 | $50.24 | $657.1K |
| PARSHALL B LYNNE | Director | 2020-11-24 | SELL | 3,910 | $50.25 | $196.5K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-11-24 | SELL | 14,690 | $50.23 | $737.9K |
| BENNETT C FRANK | Chief Scientific Officer | 2020-11-03 | SELL | 15,000 | $46.77 | $701.6K |
| KLEIN JOSEPH III | Director | 2020-10-20 | SELL | 2,889 | $46.86 | $135.4K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-09-22 | SELL | 52,000 | $50.4 | $2620.8K |
| Monia Brett P | CEO | 2020-09-01 | SELL | 314 | $53.7 | $16.9K |
| Castleman Breaux | Director | 2020-06-25 | SELL | 10,000 | $60 | $600K |
| BENNETT C FRANK | EVP, Chief Scientific Officer | 2020-06-25 | SELL | 15,000 | $59.77 | $896.6K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-06-25 | SELL | 14,914 | $59.67 | $889.9K |
| BERTHELSEN SPENCER R | Director | 2020-06-23 | SELL | 15,000 | $58.76 | $881.4K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-06-19 | SELL | 27,000 | $58.08 | $1568.2K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-03-25 | SELL | 16,000 | $47 | $752K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-03-19 | SELL | 16,000 | $45.16 | $722.6K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-03-17 | SELL | 20,390 | $44.75 | $912.5K |
| CROOKE STANLEY T | Exec Chairman of the Board | 2020-03-17 | SELL | 20,000 | $44.75 | $895K |
| O'NEIL PATRICK R. | SVP & General Counsel | 2020-02-10 | SELL | 3,882 | $59.6 | $231.4K |
| Monia Brett P | CEO | 2020-01-02 | SELL | 173 | $60.25 | $10.4K |
| KLEIN JOSEPH III | Director | 2019-12-23 | SELL | 1,000 | $61.87 | $61.9K |
| KLEIN JOSEPH III | Director | 2019-12-16 | SELL | 1,000 | $65.45 | $65.5K |
| KLEIN JOSEPH III | Director | 2019-12-09 | SELL | 1,000 | $63.74 | $63.7K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2019-12-04 | SELL | 4,566 | $65 | $296.8K |
| Geary Richard S | SVP, Development | 2019-12-04 | SELL | 10,000 | $65 | $650K |
| KLEIN JOSEPH III | Director | 2019-12-02 | SELL | 1,000 | $64.08 | $64.1K |
| Geary Richard S | SVP, Development | 2019-12-02 | SELL | 5,000 | $65.06 | $325.3K |
| KLEIN JOSEPH III | Director | 2019-11-25 | SELL | 812 | $62.9 | $51.1K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2019-11-25 | SELL | 4,000 | $62.5 | $250K |
| KLEIN JOSEPH III | Director | 2019-11-20 | SELL | 2,000 | $60 | $120K |
| Monia Brett P | COO & SVP, Translational Med | 2019-11-20 | SELL | 5,776 | $60.01 | $346.6K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2019-11-19 | SELL | 4,000 | $58.8 | $235.2K |
| CROOKE STANLEY T | Chairman and CEO | 2019-08-21 | SELL | 22,000 | $71.52 | $1573.4K |
| CROOKE STANLEY T | Chairman & CEO | 2019-07-18 | SELL | 10,000 | $70.25 | $702.5K |
| Monia Brett P | COO | 2019-07-02 | SELL | 210 | $66.4 | $13.9K |
| BERTHELSEN SPENCER R | Director | 2019-06-24 | SELL | 15,000 | $63.67 | $955.1K |
| MUTO FREDERICK T | Director | 2019-06-04 | SELL | 15,000 | $65.29 | $979.4K |
| MUTO FREDERICK T | Director | 2019-05-06 | SELL | 8,000 | $72.75 | $582K |
| PARSHALL B LYNNE | Director | 2019-04-29 | SELL | 50,000 | $75.01 | $3750.5K |
| CROOKE STANLEY T | Chairman and CEO | 2019-04-16 | SELL | 32,000 | $84.84 | $2714.9K |
| Geary Richard S | SVP, Development | 2019-04-08 | SELL | 46,240 | $84.01 | $3884.6K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-04-05 | SELL | 49,528 | $83.99 | $4159.9K |
| WENDER JOSEPH H | Director | 2019-03-19 | SELL | 10,000 | $79.63 | $796.3K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-03-18 | SELL | 28,800 | $78.79 | $2269.2K |
| PARSHALL B LYNNE | Director | 2019-03-12 | SELL | 8,334 | $75 | $625.1K |
| PARSHALL B LYNNE | Director | 2019-02-27 | SELL | 8,333 | $70 | $583.3K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-02-27 | SELL | 26,800 | $68.01 | $1822.7K |
| CROOKE STANLEY T | Chairman and CEO | 2019-02-26 | SELL | 77,000 | $60.77 | $4679.3K |
| CROOKE STANLEY T | Chairman and CEO | 2019-02-13 | SELL | 46,904 | $60.09 | $2818.5K |
| Geary Richard S | SVP, Development | 2019-02-13 | SELL | 999 | $60 | $59.9K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-02-12 | SELL | 275 | $59.5 | $16.4K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-02-05 | SELL | 19,600 | $59.25 | $1161.3K |
| BENNETT C FRANK | SVP, Antisense Research | 2019-02-01 | SELL | 9,013 | $58.29 | $525.4K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2019-01-03 | SELL | 4,400 | $54.8 | $241.1K |
| Monia Brett P | COO | 2019-01-02 | SELL | 214 | $53.5 | $11.4K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2018-12-19 | SELL | 4,063 | $52.03 | $211.4K |
| BENNETT C FRANK | SVP, Antisense Research | 2018-11-01 | SELL | 12,500 | $49.54 | $619.3K |
| Monia Brett P | COO | 2018-08-27 | SELL | 16,493 | $54 | $890.6K |
| BENNETT C FRANK | SVP, Antisense Research | 2018-08-08 | SELL | 12,500 | $45 | $562.5K |
| Monia Brett P | COO | 2018-07-24 | SELL | 156 | $47.03 | $7.3K |
| BERTHELSEN SPENCER R | Director | 2018-06-25 | SELL | 15,000 | $42.3 | $634.5K |
| MUTO FREDERICK T | Director | 2018-05-31 | SELL | 15,000 | $46.45 | $696.8K |
| WENDER JOSEPH H | Director | 2018-05-11 | SELL | 15,000 | $45.31 | $679.7K |
| BENNETT C FRANK | SVP, Antisense Research | 2018-05-11 | SELL | 12,500 | $45 | $562.5K |
| CROOKE STANLEY T | Chairman and CEO | 2018-04-17 | SELL | 13,962 | $44.4 | $619.9K |
| KLEIN JOSEPH III | Director | 2018-03-29 | SELL | 2,000 | $46.15 | $92.3K |
| KLEIN JOSEPH III | Director | 2018-03-15 | SELL | 2,000 | $51.13 | $102.3K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2018-03-12 | SELL | 1,000 | $55 | $55K |
| KLEIN JOSEPH III | Director | 2018-02-28 | SELL | 3,000 | $51.91 | $155.7K |
| KLEIN JOSEPH III | Director | 2018-02-15 | SELL | 3,000 | $48.99 | $147K |
| BENNETT C FRANK | SVP, Antisense Research | 2018-02-01 | SELL | 12,500 | $52.5 | $656.3K |
| KLEIN JOSEPH III | Director | 2018-01-30 | SELL | 3,000 | $52.86 | $158.6K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2018-01-29 | SELL | 355 | $55 | $19.5K |
| CROOKE STANLEY T | Chairman and CEO | 2018-01-29 | SELL | 11,000 | $54.12 | $595.3K |
| O'NEIL PATRICK R. | SVP Legal & General Counsel | 2018-01-25 | SELL | 645 | $55 | $35.5K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2018-01-16 | SELL | 2,724 | $51.76 | $141K |
| KLEIN JOSEPH III | Director | 2018-01-16 | SELL | 3,000 | $52.52 | $157.6K |
| Geary Richard S | SVP, Development | 2018-01-16 | SELL | 2,723 | $51.76 | $140.9K |
| PARSHALL B LYNNE | Director | 2018-01-16 | SELL | 5,986 | $51.76 | $309.8K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2018-01-16 | SELL | 2,697 | $51.76 | $139.6K |
| Boyce Sarah | Chief Business Officer | 2018-01-16 | SELL | 2,196 | $51.76 | $113.7K |
| BENNETT C FRANK | SVP, Antisense Research | 2018-01-16 | SELL | 2,696 | $51.76 | $139.5K |
| Monia Brett P | COO | 2018-01-16 | SELL | 2,821 | $51.76 | $146K |
| CROOKE STANLEY T | Chairman and CEO | 2018-01-15 | SELL | 16,549 | $51.76 | $856.6K |
| CROOKE STANLEY T | Chairman and CEO | 2018-01-08 | SELL | 11,000 | $52.01 | $572.1K |
| CROOKE STANLEY T | Chairman and CEO | 2018-01-03 | SELL | 22,000 | $50.01 | $1100.2K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2018-01-02 | SELL | 163 | $50 | $8.2K |
| KLEIN JOSEPH III | Director | 2017-12-29 | SELL | 3,000 | $50.56 | $151.7K |
| KLEIN JOSEPH III | Director | 2017-12-15 | SELL | 3,000 | $51.69 | $155.1K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2017-12-15 | SELL | 5,000 | $52.55 | $262.8K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2017-12-04 | SELL | 4,000 | $57 | $228K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-12-01 | SELL | 1,000 | $55.5 | $55.5K |
| KLEIN JOSEPH III | Director | 2017-11-30 | SELL | 3,000 | $53.55 | $160.7K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2017-11-29 | SELL | 6,000 | $53.02 | $318.1K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2017-11-16 | SELL | 7,000 | $54.35 | $380.5K |
| KLEIN JOSEPH III | Director | 2017-11-15 | SELL | 2,250 | $53.56 | $120.5K |
| KLEIN JOSEPH III | Director | 2017-11-13 | SELL | 3,000 | $55.39 | $166.2K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-11-01 | SELL | 1,000 | $58.35 | $58.4K |
| BENNETT C FRANK | SVP, Antisense Research | 2017-10-18 | SELL | 12,250 | $65 | $796.3K |
| PARSHALL B LYNNE | COO | 2017-10-18 | SELL | 16,118 | $65 | $1047.7K |
| CROOKE STANLEY T | Chairman and CEO | 2017-10-13 | SELL | 16,500 | $59.46 | $981.1K |
| Geary Richard S | SVP, Development | 2017-10-13 | SELL | 8,268 | $60 | $496.1K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-10-05 | SELL | 1,000 | $55 | $55K |
| CROOKE STANLEY T | Chairman and CEO | 2017-10-04 | SELL | 27,500 | $52.89 | $1454.5K |
| O'NEIL PATRICK R. | SVP, Legal and General Counsel | 2017-09-06 | SELL | 1,000 | $55 | $55K |
| BENNETT C FRANK | SVP, Antisense Research | 2017-07-24 | SELL | 10,000 | $59.29 | $592.9K |
| CROOKE STANLEY T | Chairman and CEO | 2017-07-20 | SELL | 11,000 | $55.35 | $608.9K |
| CROOKE STANLEY T | Chairman and CEO | 2017-07-17 | SELL | 16,500 | $52.45 | $865.4K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2017-07-03 | SELL | 309 | $51.35 | $15.9K |
| CROOKE STANLEY T | Chairman and CEO | 2017-07-03 | SELL | 16,500 | $52.1 | $859.7K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-06-01 | SELL | 70 | $48 | $3.4K |
| MUTO FREDERICK T | Director | 2017-05-31 | SELL | 12,500 | $45.22 | $565.3K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-05-01 | SELL | 650 | $48.75 | $31.7K |
| CROOKE STANLEY T | Chairman and CEO | 2017-04-25 | SELL | 16,500 | $47.81 | $788.9K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-04-24 | SELL | 500 | $45 | $22.5K |
| CROOKE STANLEY T | Chairman and CEO | 2017-04-19 | SELL | 5,500 | $43.25 | $237.9K |
| CROOKE STANLEY T | Chairman and CEO | 2017-04-13 | SELL | 22,000 | $40.69 | $895.2K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-04-12 | SELL | 1,000 | $40.07 | $40.1K |
| BENNETT C FRANK | SVP, Antisense Research | 2017-03-03 | SELL | 5,000 | $55 | $275K |
| CROOKE STANLEY T | Chairman and CEO | 2017-03-02 | SELL | 12,100 | $51.05 | $617.7K |
| PARSHALL B LYNNE | COO | 2017-03-01 | SELL | 4,625 | $49.26 | $227.8K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-03-01 | SELL | 1,500 | $49.29 | $73.9K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-02-06 | SELL | 1,500 | $46.17 | $69.3K |
| Geary Richard S | SVP, Development | 2017-01-17 | SELL | 2,441 | $46.29 | $113K |
| Boyce Sarah | Chief Business Officer | 2017-01-17 | SELL | 1,361 | $46.29 | $63K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2017-01-17 | SELL | 2,502 | $46.29 | $115.8K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2017-01-17 | SELL | 2,246 | $46.29 | $104K |
| BENNETT C FRANK | SVP, Antisense Research | 2017-01-17 | SELL | 2,421 | $46.29 | $112.1K |
| CROOKE STANLEY T | Chairman and CEO | 2017-01-17 | SELL | 15,957 | $46.29 | $738.6K |
| PARSHALL B LYNNE | COO | 2017-01-17 | SELL | 7,246 | $46.29 | $335.4K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2017-01-17 | SELL | 2,273 | $46.29 | $105.2K |
| CROOKE STANLEY T | Chairman and CEO | 2017-01-10 | SELL | 13,200 | $49.25 | $650.1K |
| CROOKE STANLEY T | Chairman and CEO | 2017-01-04 | SELL | 18,700 | $48.89 | $914.2K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2017-01-03 | SELL | 309 | $48.6 | $15K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2016-12-20 | SELL | 130 | $52.48 | $6.8K |
| PARSHALL B LYNNE | COO | 2016-12-15 | SELL | 4,000 | $50 | $200K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2016-12-05 | SELL | 2,500 | $46.05 | $115.1K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-12-05 | SELL | 350 | $45 | $15.8K |
| PARSHALL B LYNNE | COO | 2016-12-01 | SELL | 12,500 | $42.23 | $527.9K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-11-14 | SELL | 1,000 | $45 | $45K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2016-11-14 | SELL | 2,500 | $47.5 | $118.8K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2016-11-11 | SELL | 5,000 | $39.75 | $198.8K |
| CROOKE STANLEY T | Chairman and CEO | 2016-11-10 | SELL | 33,000 | $37.72 | $1244.8K |
| BENNETT C FRANK | SVP, Antisense Research | 2016-11-09 | SELL | 22,805 | $37.56 | $856.6K |
| BENNETT C FRANK | SVP, Antisense Research | 2016-11-07 | SELL | 5,000 | $34 | $170K |
| CROOKE STANLEY T | Chairman and CEO | 2016-10-05 | SELL | 11,000 | $36.61 | $402.7K |
| CROOKE STANLEY T | Chairman and CEO | 2016-09-27 | SELL | 22,000 | $36.02 | $792.4K |
| CROOKE STANLEY T | Chairman and CEO | 2016-09-21 | SELL | 22,000 | $35.5 | $781K |
| PARSHALL B LYNNE | COO | 2016-09-01 | SELL | 12,500 | $29.88 | $373.5K |
| MUTO FREDERICK T | Director | 2016-05-31 | SELL | 12,500 | $22.31 | $278.9K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-04-06 | SELL | 1,000 | $45 | $45K |
| CROOKE STANLEY T | Chairman and CEO | 2016-04-06 | SELL | 11,000 | $46.13 | $507.4K |
| CROOKE STANLEY T | Chairman and CEO | 2016-03-31 | SELL | 11,000 | $40.74 | $448.1K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-03-23 | SELL | 1,000 | $45.4 | $45.4K |
| CROOKE STANLEY T | Chairman and CEO | 2016-01-19 | SELL | 13,401 | $41.46 | $555.6K |
| HOUGEN ELIZABETH L | SVP, Finance & CFO | 2016-01-19 | SELL | 1,899 | $41.46 | $78.7K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-01-19 | SELL | 1,871 | $41.46 | $77.6K |
| PARSHALL B LYNNE | COO & Secretary | 2016-01-19 | SELL | 5,192 | $41.46 | $215.3K |
| Geary Richard S | SVP, Development | 2016-01-19 | SELL | 2,162 | $41.46 | $89.6K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2016-01-19 | SELL | 2,208 | $41.46 | $91.5K |
| Boyce Sarah | Chief Business Officer | 2016-01-19 | SELL | 872 | $41.46 | $36.2K |
| BENNETT C FRANK | SVP, Antisense Research | 2016-01-19 | SELL | 2,110 | $41.46 | $87.5K |
| CROOKE STANLEY T | Chairman and CEO | 2016-01-05 | SELL | 5,500 | $62.1 | $341.6K |
| PARSHALL B LYNNE | COO & Secretary | 2016-01-04 | SELL | 809 | $61.05 | $49.4K |
| O'NEIL PATRICK R. | SVP, Legal & General Counsel | 2016-01-04 | SELL | 1,000 | $61.1 | $61.1K |
| Monia Brett P | SVP, Antisense Drug Discovery | 2016-01-04 | SELL | 127 | $61 | $7.7K |
| CROOKE STANLEY T | Chairman and CEO | 2016-01-04 | SELL | 11,000 | $61.05 | $671.6K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked